Τίτλος – Title
|
Το Υδρόθειο Επάγει την Αγγειογένεση Hydrogen Sulphide Induces Angiogenesis |
|
Συγγραφέας – Author
|
Αναστασία Πυριόχου1, Αντωνία Μαραζιώτη1, Csaba Szabo2 και Ανδρέας Παπαπετρόπουλος1 1Εργαστήριο Μοριακής Φαρμακολογίας, Τμήμα Φαρμακευτικής, Πανεπιστήμιο Πάτρας, Πάτρα, Ελλας. 2Ikaria, Inc, Seattle, Washington Anastasia Pyriochou1, Antonia Marazioti1, Csaba Szabo2 and Andreas Papapetropoulos1 1Laboratory of Molecular Pharmacology, Department of Pharmacy, University of Patras, Patras, Hellas; 2Ikaria, Inc, Seattle, Washington, USA |
|
Παραπομπή – Citation
|
Πυριόχου,Α., Μαραζιώτη,Α., Szabo,C., Παπαπετρόπουλος,Α. : Το Υδρόθειο Επάγει την Αγγειογένεση, Επιθεώρηση Κλιν. Φαρμακολ. Φαρμακοκινητ. 27: 40-41 (2009)
Pyriochou,A., Marazioti,A., Szabo,C., Papapetropoulos,A. : Hydrogen Sulphide Induces Angiogenesis, Epitheorese Klin. Farmakol. Farmakokinet. 27: 40-41 (2009)
|
|
Ημερομηνία Δημοσιευσης – Publication Date
|
8 Μαρτίου 2009 – 2009-03-08
|
|
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek |
|
Παραγγελία – Αγορά –
Order – Buy |
||
Λέξεις κλειδιά – Keywords
|
Υδρόθειο, αγγειογένεση, κινάσες, κανάλια K+ATP, hsp27
Hydrogen sulphide, angiogenesis, kinases, K+ATP channels, hsp27
|
|
Λοιποί Όροι – Other Terms
|
Άρθρο Article |
|
Περίληψη – Summary
|
– Hydrogen sulphide (H2S) is emerging as an important signalling molecule in the cardiovascular and neuronal systems. Although H2S is known to relax vascular smooth muscle leading to a reduction in blood pressure, the role of this gaseous mediator in other aspects of the biology of vascular cells remains largely unexplored. In order to study the effects of H2S on neovascularisation, we have utilised an aqueous formulation of H2S. Incubation of endothelial cells (EC) with H2S enhanced their angiogenic potential as it promoted cell growth, migration and capillary morphogenesis on matrigel. In line with the in vitro observations, treatment of chicken chorioallantoic membranes (CAM) with H2S increased vascular length. Morever, exposure of EC to H2S resulted in increased phosphorylation of kinases linked to angiogenic responses, namely Akt, ERK and p38. Pretreatment of cells with the KATP channel blocker glibenclamide or the p38 inhibitor SB203580 abolished H2S-induced motility. Since glibenclamide inhibited H2S-triggered p38 phosphorylation, we propose that KATP channels lay upstream of p38. Once activated, p38 phosphorylates the actin-binding protein hsp27 to promote cell motility, as hsp27 silencing reduced H2S-driven migration. To determine whether endogenously produced H2S, similarly to exogensouly applied H2S drives the angiogenic response, CAMs were treated with PAG, an inhibitor of H2S biosynthesis; indeed, PAG-treated membranes displayed reduced vessel length and branching. Finally, pretreatment of cells with PAG or glibenclamide blocked vascular-endothelial growth factor-induced migration. In conclusion, we provide evidence that endogenously produced or exogenously administered H2S stimulates EC properties associated with angiogenesis through a KATP channel/MAPK pathway. |
|
Αναφορές – References
|
– |
Online ISSN 1011-6575
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Articles published in this Journal are Indexed or Abstracted in:
• Chemical Abstracts
• Elsevier’s Bibliographic Databases: Scopus, EMBASE, EMBiology, Elsevier BIOBASE
SCImago Journal and Country Rank Factor
Τι είναι η Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση-Οδηγίες προς τους Συγγραφείς
What is Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition-Instrunctions to Authors
Άρθρα Δημοσιευμένα στην Επιθεώρηση Κλινικής Φαρμακολογίας και Φαρμακοκινητικής-Ελληνική Έκδοση
Articles Published in Epitheorese Klinikes Farmakologias και Farmakokinetikes-Greek Edition
Συντακτικη Επιτροπή-Editorial Board
ΕΤΗΣΙΑ ΣΥΝΔΡΟΜΗ – ANNUAL SUBSCRIPTION
|
||
Γλώσσα Πλήρους Κειμένου –
Full Text Language |
Ελληνικά – Greek
|
|
Παραγγελία – Αγορά –
Order – Buy |
pharmakonpress[at]pharmakonpress[.]gr
|
|
pharmakonpress[at]pharmakonpress[.]gr
|